browse Browse

pac.dog pac.dog / Lobbying

1st Quarter - Report · 2026

Filing UUID
fafdebd1-06a7-4bf1-8c28-ccc756fa3f4a
Type
Q1 — 1st Quarter - Report
Period
first_quarter
Year
2026
Posted
2026-04-20 20:29:23
Income (reported)
Expenses (reported)
$520,000
Expenses method
A
Filing document
Open on lda.senate.gov

Registrant (lobbying firm)

EXELIXIS INC.

Genomics-based drug discovery company

Contact
JAMES FENTON
Phone
+1 202-536-7683
Address
zip:94502, city:Alameda, state:CA, street:1851 Harbor Bay Parkway

Client

EXELIXIS INC.

State
CA
Country
US
Government-entity client
false
Effective date
2019-03-01

Issues lobbied + lobbyists

HCR — Health Issues

Proposals related to drug pricing including the Administrations Most-Favored-Nation Prescription Drug Pricing proposal, implementation of drug-related provisions of the Inflation Reduction Act, and administration of the 340B Drug Pricing Program. PBM reform proposals. The Help Ensure Lower Patient (HELP) Copays Act. Intellectual property proposals relating to life sciences. S.1930/HR 3731, Small Biotech Innovation Act. Health agency funding levels.

Lobbyists:

Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE

TAX — Taxation/Internal Revenue Code

IRC Section 174 amortization of R&D expenditures.

Lobbyists:

Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE

pac.dog is a free, independent, non-partisan research tool. Every candidate, committee, bill, vote, member, and nonprofit on this site is mirrored from primary U.S. government sources (FEC, congress.gov, govinfo.gov, IRS) and each state's Secretary of State / election commission — no third-party data vendors, no paywall, no editorial intermediation. Citations to the originating source are on every detail page.